On June 26, 2014, Dr. Ning Zhiqiang, vice president of research and development of Shenzhen CHIPSCREEN BIOSCIENCES, was invited to attend the 2014 post- ASCO conference information exchange meeting and pan – pearl river delta tumor progress symposium ( CS WOG ) and the annual meeting of Guangdong anti-cancer association - lymphoma Asia Pacific expert seminar held in Guangzhou, and gave a report entitled " Chidamide, a New Subtype-selective Oral Histone Deacetylase Inhibitor for Peripheral T-cell Lymphoma, and a World-wide Update for Clinical Development ". At the meeting, Dr. Ning shared Chidamide's clinical research and results on peripheral T-cell lymphoma with lymphoma clinical experts from home and abroad, including Professor Lin tongyu and Professor Takeshi Takahashi.